Longview Acquisition Corp. II (LGV) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
767 FIFTH AVENUE NEW YORK, NY 10153 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)
| 9/30/2022 MRQ | 12/31/2021 | |||
|---|---|---|---|---|
| ASSETS | ||||
| Current Assets | ||||
| Cash, cash equivalents, and short-term investments | 6,563 | |||
| Cash and cash equivalents | 6,563 | |||
| Prepaid expense | 663,130 | |||
| Total current assets: | 669,693 | |||
| Noncurrent Assets | ||||
| Asset, held-in-trust | 690,148,899 | |||
| Total noncurrent assets: | 690,148,899 | |||
| TOTAL ASSETS: | 690,818,592 | |||
| LIABILITIES AND EQUITY | ||||
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities, including: | 2,235,219 | |||
| Other undisclosed accounts payable and accrued liabilities | 2,235,219 | |||
| Due to related parties | 1,934,656 | |||
| Total current liabilities: | 4,169,875 | |||
| Noncurrent Liabilities | ||||
| Liabilities, other than long-term debt | 20,060,000 | |||
| Derivative instruments and hedges, liabilities | 20,060,000 | |||
| Other undisclosed noncurrent liabilities | 22,225,000 | |||
| Total noncurrent liabilities: | 42,285,000 | |||
| Total liabilities: | 46,454,875 | |||
| Temporary equity, carrying amount | 690,000,000 | |||
| Equity | ||||
| Equity, attributable to parent, including: | (45,636,283) | |||
| Accumulated deficit | (45,638,008) | |||
| Other undisclosed equity, attributable to parent | 1,725 | |||
| Total equity: | (45,636,283) | |||
| TOTAL LIABILITIES AND EQUITY: | 690,818,592 | |||
Income Statement (P&L) (USD)
| 9/30/2022 TTM | 12/31/2021 | ||
|---|---|---|---|
| Operating expenses | (4,947,619) | ||
| Operating loss: | (4,947,619) | ||
| Nonoperating income | 12,349,114 | ||
| Investment income, nonoperating | 13,284,899 | ||
| Income from continuing operations before income taxes: | 7,401,495 | ||
| Income tax benefit | 1,007,731 | ||
| Income from continuing operations: | 8,409,226 | ||
| Income before gain (loss) on sale of properties: | ✕ | 8,409,226 | |
| Net income: | 8,409,226 | ||
| Other undisclosed net loss attributable to parent | (1,007,731) | ||
| Net income available to common stockholders, diluted: | 7,401,495 | ||
Comprehensive Income (USD)
| 9/30/2022 TTM | 12/31/2021 | ||
|---|---|---|---|
| Net income: | 8,409,226 | ||
| Comprehensive income, net of tax, attributable to parent: | 8,409,226 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.